Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis

2019-03-01
Petljak, Mia
Alexandrov, Ludmil B.
Brammeld, Jonathan S.
Price, Stacey
Wedge, David C.
Grossmann, Sebastian
Dawson, Kevin J.
Ju, Young Seok
Iorio, Francesco
Tubio, Jose M. C.
Koh, Ching Chiek
Georgakopoulos-Soares, Ilias
Rodriguez-Martin, Bernardo
Otlu Sarıtaş, Burçak
O'Meara, Sarah
Butler, Adam P.
Menzies, Andrew
Bhosle, Shriram G.
Raine, Keiran
Jones, David R.
Teague, Jon W.
Beal, Kathryn
Latimer, Calli
O'Neill, Laura
Zamora, Jorge
Anderson, Elizabeth
Patel, Nikita
Maddison, Mark
Ng, Bee Ling
Graham, Jennifer
Garnett, Mathew J.
McDermott, Ultan
Nik-Zainal, Serena
Campbell, Peter J.
Stratton, Michael R.
Show full item record
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
172
views
87
downloads
Multiple signatures of somatic mutations have been identified in cancer genomes. Exome sequences of 1,001 human cancer cell lines and 577 xenografts revealed most common mutational signatures, indicating past activity of the underlying processes, usually in appropriate cancer types. To investigate ongoing patterns of mutational-signature generation, cell lines were cultured for extended periods and subsequently DNA sequenced. Signatures of discontinued exposures, including tobacco smoke and ultraviolet light, were not generated in vitro. Signatures of normal and defective DNA repair and replication continued to be generated at roughly stable mutation rates. Signatures of APOBEC cytidine deaminase DNA-editing exhibited substantial fluctuations in mutation rate over time with episodic bursts of mutations. The initiating factors for the bursts are unclear, although retrotransposon mobilization may contribute. The examined cell lines constitute a resource of live experimental models of mutational processes, which potentially retain patterns of activity and regulation operative in primary human cancers.
mutational signatures, cancer cell lines, xenografts, APOBEC deaminases, episodic mutagenesis
https://hdl.handle.net/11511/96881
Graduate School of Informatics, Article

Suggestions

Characterization and promoter identification of metastasis associated protein 1 in human colorectal carcinoma cell lines
Tunçay Çağatay, Seda; Erson Bensan, Ayşe Elif; Department of Biology (2014)
Metastasis associated protein 1 (MTA1) is a member of the nuclear remodeling and histone deacetylase (NuRD) complex, which is known to repress the expression of several tumor suppressor genes and has been widely linked to tumor metastasis. 15-lipoxygenase-1 (15-LOX-1) is a lipid metabolizing enzyme that has tumor suppressive properties and is silenced by the NuRD complex in colorectal cancer (CRC). We have previously shown that reexpression of 15-LOX-1 inhibited metastasis in CRC, inhibited the inflammatory...
Label-free enrichment of MCF7 breast cancer cells from leukocytes using continuous flow dielectrophoresis
Arslan, Zeynep Caglayan; Yalcin, Yagmur Demircan; Külah, Haluk (2022-04-01)
Circulating tumor cells (CTCs) present in the bloodstream are strongly linked to the invasive behavior of cancer; therefore, their detection holds great significance for monitoring disease progression. Currently available CTC isolation tools are often based on tumor-specific antigen or cell size approaches. However, these techniques are limited due to the lack of a unique and universal marker for CTCs, and the overlapping size between CTCs and regular blood cells. Dielectrophoresis (DEP), governed by the in...
Evaluation of methylation profiles of an epidermal growth factor receptor gene in a head and neck squamous cell carcinoma patient group
Mutlu, M.; Mutlu, Pelin; Azarkan, S.; Baylr, Ö.; Öcal, B.; Saylam, G.; KORKMAZ, MEHMET HAKAN (2021-03-23)
Upregulation of the epidermal growth factor receptor (EGFR) gene has shown an important impact on the development of head and neck cancers due to its important regulation role on multiple cell signaling pathways. The aim of this study was to investigate the methylation pattern of the promoter region of the EGFR gene between head and neck squamous cell carcinoma (HNSCC) patients and a control group. Forty-seven unrelated HNSCC patients, clinically diagnosed at the Department of Otorhinolaryngology, Dlşkapl Y...
Pan-cancer clinical impact of latent drivers from double mutations
Yavuz, Bengi Ruken; Tsai, Chung-Jung; Nussinov, Ruth; Tuncbag, Nurcan (2023-12-01)
Here, we discover potential ‘latent driver’ mutations in cancer genomes. Latent drivers have low frequencies and minor observable translational potential. As such, to date they have escaped identification. Their discovery is important, since when paired in cis, latent driver mutations can drive cancer. Our comprehensive statistical analysis of the pan-cancer mutation profiles of ~60,000 tumor sequences from the TCGA and AACR-GENIE cohorts identifies significantly co-occurring potential latent drivers. We ob...
Novel BRCA2 pathogenic genotype and breast cancer phenotype discordance in monozygotic triplets
Duzkale, Neslihan; EYERCİ, NİLNUR; Oksuzoglu, Berna; Teker, Taner; Kandemir, Olcay (Elsevier BV, 2020-04-01)
BRCA1/2 genes with high-penetrance are tumor suppressor and tumor susceptibility genes that play important roles in the homologous recombination mechanism in DNA repair and increase breast cancer risk. Variants in BRCA1 or BRCA2 are the main causes of familial and early-onset breast cancer. This study investigated pathogenic variant belonging to the BRCA2 gene splice region in monozygotic triplets. A 44-year-old woman was diagnosed with breast cancer when she was 32 years old. Her monozygotic sister had a h...
Citation Formats
M. Petljak et al., “Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis,” CELL, vol. 176, no. 6, pp. 1282–1314, 2019, Accessed: 00, 2022. [Online]. Available: https://hdl.handle.net/11511/96881.
METU IIS - Integrated Information Service open@metu.edu.tr